Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
Delmar pharmaceuticals shares decline on thursday after being uplisted to nasdaq
By Gregg Greenberg
Jul 14, 2016 6:09 PM EDT
PRESS RELEASES
DelMar Announces Approval Of Merger By Stockholders
By PR Newswire
Aug 17, 2020 8:30 AM EDT
PRESS RELEASES
DelMar Pharmaceuticals To Host Conference Call To Discuss Proposed Acquisition Of Adgero Pharmaceuticals
By PR Newswire
Jul 17, 2020 8:00 AM EDT
PRESS RELEASES
Global Coalition For Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 To Participate In The GBM AGILE Pivotal Study, An Adaptive Clinical Trial Platform In Glioblastoma Multiforme
By PR Newswire
Jun 4, 2020 8:00 AM EDT
PRESS RELEASES
DelMar Pharmaceuticals To Present Updates Of Two Phase 2 Clinical Trials Of VAL-083 At The 2020 American Association For Cancer Research Virtual Annual Meeting II
By PR Newswire
Jun 1, 2020 8:00 AM EDT
PRESS RELEASES
DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update In Phase 2 Clinical Trial Of VAL-083 For Adjuvant Treatment Of Brain Tumors
By PR Newswire
May 5, 2020 8:00 AM EDT
PRESS RELEASES
DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension
By PR Newswire
Mar 26, 2020 8:00 AM EDT
PRESS RELEASES
DelMar Pharmaceuticals [Nasdaq:DMPI] Enrolls Final Patient In Phase 2 Clinical Trial Of VAL-083 For First-Line Treatment Of Brain Tumors
By PR Newswire
Feb 19, 2020 8:00 AM EST
PRESS RELEASES
DelMar Pharmaceuticals To Attend The 22nd Annual BIO CEO & Investor Conference In New York City February 10 And 11, 2020
By PR Newswire
Feb 5, 2020 8:00 AM EST
PRESS RELEASES
DelMar Pharmaceuticals Announces Peer-Reviewed Publication Of Interim Results Of Phase 2 Clinical Trial Of VAL-083 As First-Line Treatment In Newly-Diagnosed MGMT-Unmethylated Glioblastoma Multiforme
By PR Newswire
Jan 29, 2020 8:00 AM EST
OPINION
Delmar pharmaceuticals shares decline on thursday after being uplisted to nasdaq
By Gregg Greenberg
Jul 14, 2016 6:09 PM EDT
VIDEO
Shares of DelMar End Lower on First Day of Trading
By Gregg Greenberg
Jul 14, 2016 4:42 PM EDT
